Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors

• Autores principales: Danielle Gilbert (Autor), Junxiao Hu (Autor), Theresa Medina (Autor), Elizabeth R. Kessler (Autor), Elaine T. Lam (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The incidence of severe immune-related adverse events (irAEs) in cancer subjects receiving immune checkpoint inhibitors (ICIs) following COVID-19 vaccination and the relationship between the incidence of severe irAE and the interval between COVID-19 vaccination and ICI dose have not been established...